Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Sun Pharma files application for arthritis drug Tildrakizumab in Japan

      Sun Pharma files application for arthritis drug Tildrakizumab in Japan

      Farhat Nasim2 Aug 2019 10:00 AM IST
      Sun Pharma is committed to growing its global dermatology franchise, with Tildrakizumab as its lead product.New Delhi: Sun Pharmaceutical on Thursday...
      GSK Consumer Healthcare net profit rises by 24 percent to Rs 248 crore in Q1

      GSK Consumer Healthcare net profit rises by 24 percent to Rs 248 crore in Q1

      Farhat Nasim2 Aug 2019 9:15 AM IST
      The company had posted a net profit of Rs 200.44 crore for the corresponding period of the previous fiscal, GlaxoSmithKline Consumer Healthcare said...
      Government appoints 108 drug inspectors pan India; Details

      Government appoints 108 drug inspectors pan India; Details

      Farhat Nasim1 Aug 2019 3:43 PM IST
      New Delhi: Through a recent Gazette notification, the Central Government has apprised about the appointment of 108 Inspectors for the country for the...
      CDSCO mandates filing of online application for veterinary drugs on new SUGAM portal

      CDSCO mandates filing of online application for veterinary drugs on new SUGAM portal

      Farhat Nasim1 Aug 2019 10:57 AM IST
      New Delhi: Through a recent notification, the apex drug regulatory body Central Drugs Standard Control Organization (CDSCO) has informed to file...
      Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

      Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

      Farhat Nasim30 July 2019 2:08 PM IST
      New Delhi: The patent protection of blockbuster anti-diabetic drug Vildagliptin manufactured by the Swiss drugmaker, Novartis, will soon expire on...
      Granules India completes USFDA inspection for Bonthapally facility with one observation

      Granules India completes USFDA inspection for Bonthapally facility with one observation

      Farhat Nasim29 July 2019 10:00 AM IST
      Granules India Ltd's Bonthapally facility is one of the world's largest single-site Paracetamol API manufacturing plant by volume. New Delhi: Drug...
      Jubilant Life Sciences net profit slips 7.68 percent to Rs 185 crore for June quarter

      Jubilant Life Sciences net profit slips 7.68 percent to Rs 185 crore for June quarter

      Farhat Nasim29 July 2019 9:00 AM IST
      "We have had a steady performance during the quarter. Pharmaceutical segment revenues have been higher by 12 per cent YoY led by growth in CMO,...
      Violation of guidelines for OTC sale of antibiotics to draw regulatory action- Health Minister

      Violation of guidelines for OTC sale of antibiotics to draw regulatory action- Health Minister

      Farhat Nasim28 July 2019 4:30 PM IST
      New Delhi: Through a recent written reply, Health Minister Dr Harsh Vardhan has apprised the parliament about the power possessed by the State...
      DOP junks Geltec plea against NPPA decision on retail price of Ibuprofen Soft Gelatin Capsules

      DOP junks Geltec plea against NPPA decision on retail price of Ibuprofen Soft Gelatin Capsules

      Farhat Nasim28 July 2019 11:30 AM IST
      New Delhi: Through a recent decision, the Department of Pharmaceuticals (DOP) has rejected the review application filed by Geltec Private Limited...
      22-member Committee Constituted to guide CDSCO on Medical Device Regulation

      22-member Committee Constituted to guide CDSCO on Medical Device Regulation

      Farhat Nasim27 July 2019 1:09 PM IST
      New Delhi: To advice the apex drug regulator, Central Drugs Standard Control Organisation (CDSCO) on matters related to the regulation and...
      Biocon appoints Mayank Verma as Company Secretary, Compliance Officer

      Biocon appoints Mayank Verma as Company Secretary, Compliance Officer

      Farhat Nasim27 July 2019 9:00 AM IST
      Prior to joining the Biocon Group, Mayank Verma has worked with ING Vysya Bank Limited from 2007 to 2012.New Delhi: Biotechnology major, Biocon has...
      Apixaban Patent: Natco gets HC relief for its upcoming medicine Apigat

      Apixaban Patent: Natco gets HC relief for its upcoming medicine Apigat

      Farhat Nasim26 July 2019 3:00 PM IST
      NEW DELHI: Days after ending a patent row over its cancer drug Regonat with Bayer, drugmaker, Natco Pharma is reported to have now been embroiled in a...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok